China L-carnosine market is estimated to grow at a CAGR of around 6% during the forecast period. China is one of the largest economies across the globe and is known for its significant economic growth, healthcare infrastructure, and technological advancement. Rising geriatric population base and increasing prevalence of chronic diseases are primarily contributing to the growth of the market. China has the highest number of adults (20-79) with diabetes across the globe. For instance, as per the International Diabetes Federation (IDF), in 2019, the number of adults with diabetes was 116.4 million in the country, which is expected to reach 140.5 million by 2030. L-carnosine is useful to prevent damage caused by too much sugar in the body. Therefore, growing diabetes patients encourages the demand for L-carnosine.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/china-l-carnosine-market
Additionally, there is a considerable presence of the aging population in the country. With the passing age, people experience various types of pain due to several health problems. There are several disorders linked with an aging body such as osteoarthritis (OA). This may increase the demand for L-carnosine in the country, as it supports joint health by encouraging healthy inflammation management.
A Full Report of China L-Carnosine Market is Available at: https://www.omrglobal.com/industry-reports/china-l-carnosine-market
China L-carnosine market is segmented on the basis of application and geography. Based on the application, the market is segmented into autism, diabetes support, skin support, CVD support, joint support, and others. Others segment include digestion support, Parkinson’s disease, and Alzheimer’s disease. In 2019, the skin support segment is projected to contribute a significant share to the global market.
Some prominent players in the market include Foodchem International Corp., Kirkman Group, Inc., Desheng International Industry Co., Ltd., and Fenchen Group Co., Ltd. Foodchem International Corp. caters more than 5,000 customers all across the globe from various industry verticals including food & beverage, pharmaceutical, cosmetics, animal nutrition, and chemical industry. The company has an Export Distribution Center (EDC) in Shanghai Yangshan Free Trade Zone from which it can deliver products in 7 days. Besides, the company has seven warehouses in China's main port, and one bonded warehouse in Belgium and the US. In its food ingredient segment, the company offers L-carnosine. The company is the supplier and manufacturer of L-carnosine for more than years. Directly the company sells at least 5 kg of L-Carnosine and quantity less than that has to be bought from the local manufacturer.
China L-Carnosine Market Segmentation
China L-carnosine Market by Application
• Autism
• Diabetes
• Skin Support
• Cardiovascular Support
• Joint Support
• Others
China L-Carnosine Market – Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East and Africa
Company Profiles
• Bachem AG
• Desheng International Industry Co., Ltd
• Fengchen Group Co.,Ltd.
• Foodchem International Corp.
• Hubei Vanz Pharm Co., Ltd.
• Kirkman Group, Inc.
• Shaanxi Shineherb Biotech Co., Ltd.
• Suzhou Fushilai Pharmaceutical Co., Ltd.
• Wuhan W&Z Biotech Co., Ltd.
• Zhejiang Aiyi tech Co., Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-l-carnosine-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email:
[email protected]
Contact no: +1 646-755-7667, +91 780-304-0404